M. Picton

发表

Epstein–Barr Virus Infection in Adult Renal Transplant Recipients

S. Roberts, P. Klapper, M. Morton, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Can a combined screening/treatment programme prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies: study protocol for the multicentre randomised controlled OuTSMART trial

R. Horne, R. Vaughan, P. McCrone, 2014, Trials.

Association Between C4d Staining in Renal Transplant Biopsies, Production of Donor-Specific HLA Antibodies, and Graft Outcome

L. McWilliam, M. Picton, Susan Martin, 2007, Transplantation.

Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.

A. Matas, K. Famulski, P. Halloran, 2015, Journal of the American Society of Nephrology : JASN.

Can direct oral anticoagulants be used in kidney transplant recipients?

J. Thachil, S. Mitra, M. Morton, 2021, Clinical transplantation.

Renal Allograft Failure After Ipilimumab Therapy for Metastatic Melanoma: A Case Report and Review of the Literature.

H. Denley, M. Morton, M. Picton, 2016, Transplantation proceedings.

Living donor kidney transplantation: often a missed opportunity.

J. Ainsworth, Roger H Jones, M. Picton, 2019, The British journal of general practice : the journal of the Royal College of General Practitioners.

Reducing cardiovascular morbidity and mortality from hypertension in end-stage renal disease

R. Foley, M. Picton, M. Picton, 2000, Current opinion in nephrology and hypertension.

Optimized immunosuppression to prevent graft failure in renal transplant recipients with HLA antibodies (OuTSMART): a randomised controlled trial

Z. Moon, Dominic Stringer, J. Stoves, 2023, EClinicalMedicine.

Dissolution of extensive urolithiasis: extending the utility of rasburicase can avoid the need for surgical intervention and renal replacement therapy

P. Selby, B. Grey, A. Hutchison, 2016, Journal of surgical case reports.

Epidemiology of Posttransplantation Lymphoproliferative Disorder in Adult Renal Transplant Recipients

S. Roberts, P. Klapper, R. Byers, 2013, Transplantation.

A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature

M. Morton, M. Picton, T. Augustine, 2019, Oncotarget.

Banff criteria as predictors of outcome following acute renal allograft rejection.

I. Roberts, C. Short, M. Picton, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Post-transplant lymphoproliferative disorder in adult renal transplant recipients: survival and prognosis

S. Roberts, P. Klapper, R. Byers, 2016, Leukemia & lymphoma.

The genetic contribution to recurrent autoimmune nephritis.

P. Brenchley, K. Poulton, M. Morton, 2014, Transplantation reviews.

rhErythropoietin-b as a tissue protective agent in kidney transplantation: a pilot randomized controlled trial

S. Roberts, P. Brenchley, D. D. de Freitas, 2015, BMC Research Notes.

Outcome of Pancreas Transplantation in Recipients Older Than 50 Years: A Single-Centre Experience

R. Pararajasingam, M. Picton, H. Riad, 2008, Transplantation.

Potential Impact of Microarray Diagnosis of T Cell–Mediated Rejection in Kidney Transplants: The INTERCOM Study

A. Matas, P. Halloran, D. Serón, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Microarray Diagnosis of Antibody‐Mediated Rejection in Kidney Transplant Biopsies: An International Prospective Study (INTERCOM)

A. Matas, P. Halloran, D. Serón, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Update to the study protocol, including statistical analysis plan, for the multicentre, randomised controlled OuTSMART trial: a combined screening/treatment programme to prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies

R. Horne, Dominic Stringer, J. Stoves, 2019, Trials.

rhErythropoietin-b as a tissue protective agent in kidney transplantation: a pilot randomized controlled trial

S. Roberts, P. Brenchley, D. D. de Freitas, 2015, BMC Research Notes.

Ban ff criteria as predictors of outcome following acute renal allograft rejection

I. Roberts, C. Short, M. Picton, 1999 .

Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure.

A. Freemont, D. Houghton, J. Hoyland, 2000, Kidney international.

Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.

A. Matas, K. Famulski, P. Halloran, 2015, Journal of the American Society of Nephrology : JASN.

Epstein–Barr Virus Infection in Adult Renal Transplant Recipients

S. Roberts, P. Klapper, M. Morton, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.